Ligand validation:5QCO

E4A: (4S)-19-acetyl-4-[(1R)-1-hydroxy-2-({1-[3-(propan-2-yl)phenyl]cyclopropyl}amino)ethyl]-11-oxa-3,16-diazatricyclo[15.3.1.1~6,10~]docosa-1(21),6(22),7,9,17,19-hexaen-2-one

E4A is a Ligand Of Interest in 5QCO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QCO_E4A_C_401	55%	39%	0.191	0.962	0.27	2.08	-	4	0	0	100%	0.9524
5QCO_E4A_A_401	48%	45%	0.211	0.956	0.32	1.78	-	3	0	0	100%	0.9524
5QCO_E4A_B_401	47%	35%	0.217	0.959	0.32	2.18	-	5	0	0	100%	0.9405

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.